Turkey Tail Mushroom Benefits: What PSK, PSP and the Whole Mushroom Have Actually Been Tested For in People

Turkey tail (Trametes versicolor, formerly Coriolus versicolor; yun zhi in Chinese medicine, kawaratake in Japan) is a bracket fungus that grows on dead hardwood across the temperate world, and it is the medicinal mushroom with the most clinical research behind its name — and the least of it about the product people actually buy. Almost all of that research is on two purified, protein-bound polysaccharides, PSK and PSP, given at pharmaceutical doses to cancer patients alongside their treatment; in healthy adults, the whole mushroom has one randomised prebiotic trial in 24 volunteers, one 100-person immune trial that combined it with another herb, and no trial at all that measured inflammation. Below is every human study we could find, with its size and duration next to every claim, an honest account of what “anti-inflammatory” rests on, and the reason our own turkey tail extract carries a lab number only when it is blended with reishi.

What is turkey tail?

A thin, leathery, fan-shaped polypore that grows in overlapping tiers on fallen logs and stumps, banded in browns, greys and blues like the fanned tail of a wild turkey. It is one of the most common fungi in the world, a white-rot decomposer of hardwood, and inedible in the ordinary sense — the fruiting body is almost pure fibre and chitin, too tough to chew or digest, which is why every traditional use is a long-simmered tea and every modern use is an extract. In Chinese medicine it is yun zhi, “cloud mushroom”, in use for some two thousand years; in Japan, kawaratake.

Its scientific name was changed from Coriolus versicolor to Trametes versicolor, and both names appear in the research — the older one on nearly all of the PSK and PSP trials, which is worth knowing when you search. What makes it interesting to researchers is a cell wall unusually rich in beta-1,3/1,6-glucans and protein-bound polysaccharides, and a fruiting body that also contains sterols, phenolic compounds and at least one immune-active protein (YZP) identified in 2013. The original opening of this article, kept below, introduces it well and makes the one distinction that matters — pharmaceutical compound versus supplement — in its first paragraph.

What are PSK and PSP — and are they in a tincture?

PSK (polysaccharide-K, sold in Japan as Krestin) and PSP (polysaccharopeptide, China) are protein-bound beta-glucans — long chains of glucose with peptide attached — produced not from the mushroom you see on a log but from cultured mycelium of two specific strains: CM-101 for PSK and COV-1 for PSP. PSP is about 60% polysaccharide and 10–30% peptide. Both have been used clinically in Asia since the 1970s. A fruiting-body tincture contains beta-glucans and protein-bound polysaccharides of the same family, but not PSK or PSP by name, not at their doses, and not in their standardised form.

That is not a mark against the tincture; it is a mark against borrowing PSK’s evidence for it. The 2002 review that laid out PSK’s proposed mechanisms — activation of natural-killer and lymphocyte-activated killer cells, upregulation of immune cytokines, an antimetastatic effect and antioxidant capacity — describes what a purified drug did at pharmaceutical doses in patients. The honest use of that literature on a supplement page is as proof of class: turkey tail’s polysaccharides are biologically active in humans, which is more than most mushrooms can say. What they do at a supplement dose in a healthy person is a separate question, answered in the next sections. The original explanation of the two compounds is kept below.

What has turkey tail actually been tested for in people?

Mostly for survival and immune recovery in cancer patients, using PSK or PSP; occasionally for immune markers or gut bacteria in healthy adults; never for inflammation in a healthy adult, and never as a tincture. The table lists every human study we could find in PubMed in which a turkey tail preparation was given by mouth and an outcome was measured. Read the “who and what” column before the “what was found” column — the population and the compound decide what a result means.

Two patterns. Every result with a hard clinical endpoint — survival, recurrence — comes from a purified polysaccharide given to patients alongside treatment. Every result in healthy people is a blood or stool marker, in a small group, over weeks to months, and in the largest of them turkey tail was combined with a second herb. Neither pattern describes a person taking a few drops of extract for general wellbeing, and no study does. The original article’s section on the three research directions is kept below; it named them correctly — microbiome, immune cells, inflammation — and the next three sections give each one its human evidence.

Does turkey tail reduce inflammation?

No human trial has measured that. The “anti-inflammatory” reputation rests on three kinds of evidence, none of it in a person: an ethanol-extractable fraction of turkey tail inhibited the inflammation enzymes lipoxygenase, cyclooxygenase-1 and cyclooxygenase-2 in a 2025 laboratory study; a 12-kDa protein purified from the fruiting body, YZP, drove mouse B cells to produce the anti-inflammatory cytokine IL-10 and eased chemically induced colitis in mice; and reviews of its polysaccharides list “anti-inflammatory” among many properties shown in cells and animals. The one trial in healthy adults that measured a cytokine found the opposite direction — more interferon-gamma, a pro-inflammatory Th1 signal — which is what an immune stimulant does.

This is not unusual for medicinal mushrooms, and the field’s own null results are instructive. When 57 older women took 900 mg a day of a well-studied Agaricus blazei extract for 60 days, IL-6, interferon-gamma and TNF-α did not move at all; when 50 patients with inflammatory bowel conditions took the same mushroom extract for 21 days in a placebo-controlled trial, the effect on systemic cytokines was “limited” even though symptoms had improved in earlier trials. The one mushroom trial in healthy people that did lower an inflammatory marker was whole shiitake, 5–10 g a day for 4 weeks, where C-reactive protein fell. The fair statement for turkey tail, then, is that its compounds interact with inflammatory pathways in the laboratory, that no one has yet checked whether that happens in a person taking it, and that in the one place it was checked the mushroom activated the immune system rather than damping it. Reishi has the better human record on the balance side — the reishi and inflammation article lays it out — which is one reason the two are paired in our blend. The original article’s transparency note, kept below, said the right thing in fewer words.

Does turkey tail support the immune system in healthy adults?

In the one large trial, yes — with an asterisk. One hundred healthy adults took yun zhi capsules (50 mg per kg of body weight, PSP-rich) together with the herb danshen for four months, then crossed over to placebo; on the herbs, their T-helper cells rose in number and proportion, the CD4/CD8 ratio increased, and their blood cells produced more interferon-gamma and expressed more IL-2 receptor when challenged. Liver, kidney and bone chemistry were unaffected. The asterisk is danshen: the trial cannot say how much of the effect was turkey tail’s.

Around it sit smaller pieces: the phase-1 study in which 6 g a day nudged NK-cell function upward in 9 women over 6 weeks; the 82-woman study after breast-cancer treatment with the same yun zhi–danshen combination and similar T-cell changes; and the 2026 vaccination trial in which a four-day course of a two-species mycelium product reduced vaccine side effects without blunting antibodies. A 2010 systematic review of dietary polysaccharides counted 15 controlled human studies across all sources and concluded that turkey tail glucan extracts “improved survival and immune function in human RCTs of cancer patients” — and that the oral polysaccharide literature as a whole was too heterogeneous for broad claims. That is the state of play: immune cells respond, in patients clearly and in healthy people probably, and nobody has counted whether a healthy adult on turkey tail gets sick less often. The wider immune picture across reishi, shiitake and cordyceps is on the mushrooms for the immune system page; the mechanism — beta-glucans and the Dectin-1 receptor — is on the turkey tail science page.

Is turkey tail a prebiotic?

It is the one medicinal mushroom with a randomised human trial that says so. In 2014, 24 healthy volunteers were assigned to PSP, to the antibiotic amoxicillin, or to nothing, and their stool was sequenced seven times over eight weeks. PSP “led to clear and consistent microbiome changes consistent with its activity as a prebiotic” without disturbing each person’s stable baseline community, while amoxicillin caused a surge of Escherichia/Shigella that had not resolved 42 days after the course ended.

The mechanism is ordinary and well described: beta-glucans and chitin are not broken down by human enzymes, reach the colon intact and are fermented there into short-chain fatty acids. What is not ordinary is having it shown in people with this mushroom. The caveats are the same as everywhere on this page — PSP is a purified polysaccharide at a pharmaceutical dose, and bacteria were counted rather than symptoms asked about — and the dose gap between grams of polysaccharide and a 1.4 ml tincture is the subject of our medicinal mushrooms and digestion article, which goes through every gut trial in the field. The original Q&A of this article is kept below; its answer on eating the raw mushroom is exactly right.

What does “over 400 clinical trials” actually refer to?

To PSK and PSP — purified, standardised, mycelium-derived pharmaceutical polysaccharides — given at pharmaceutical doses — PSP at 50 mg per kg of body weight in the trials above — to cancer patients alongside surgery, chemotherapy or radiotherapy, mostly in Japan and China since the 1970s. The number itself usually counts preclinical papers too. It is a real body of work; it is not a body of work about the capsule or dropper bottle on the page that quotes it.

What can honestly be carried across is this. First, the class of molecule: turkey tail’s protein-bound beta-glucans are biologically active in humans, which is why we measure beta-glucan on our finished extract rather than “total polysaccharides”, a figure that starch inflates. Second, the safety record: across decades of use and the trials above, the adverse effects have been mild and gastrointestinal. What cannot be carried across is the outcome — survival in cancer care is not a wellness claim, and we do not make it. The two Japanese meta-analyses (8,009 and 1,094 patients) and the 2022 Cochrane review are cited here so that you can see the evidence’s actual shape: excellent for a prescription adjunct, absent for a tincture. The beta-glucan versus polysaccharides page explains why the measured number matters more than the borrowed trial count.

Does turkey tail interact with medication?

Less than most herbs, on the one enzyme tested: 14 days of a commercial PSP product at 1,200 mg three times a day produced no clinically significant change in CYP3A4 activity in 12 healthy adults — the enzyme responsible for metabolising roughly half of prescription drugs. The authors were careful to add that other metabolic pathways were not studied. Beyond that, the caution is the one that applies to every beta-glucan source: a substance that makes immune cells more responsive is something your physician must know about if you take an immunosuppressant or a biologic, have an autoimmune condition, or have had a transplant.

Two further points from the trials. The 4-month healthy-adult trial found no adverse effects on liver or kidney function, and the cancer-care literature reports mostly grade 2 or lower adverse effects. And because our turkey tail is blended with reishi, reishi’s documented anti-platelet activity applies to the product: people on anticoagulants should ask before starting, and everyone should stop two weeks before surgery. The drug-interactions page lists what is documented for each mushroom; the side-effects page lists what the trials reported.

How much turkey tail did the trials use, and in which form?

Grams of preparation or a weight-based dose of purified polysaccharide — never drops. The phase-1 study used 3, 6 and 9 g a day of a turkey tail preparation; the healthy-adult immune trial used 50 mg of PSP-rich yun zhi per kilogram of body weight a day (about 3.5 g for a 70 kg adult); the CYP3A4 study used 3.6 g a day of a PSP product. Our label dose is 1.4 ml of extract a day, and we will not pretend the two convert.

What we can state exactly is what is in our bottle. The Turkey Tail + Reishi extract is a triple extraction — water, alcohol and ultrasonic — of fresh fruiting bodies. Separately, the mushroom-to-liquid ratio is 1:3, which means about 16–17 g of fresh mushroom in every 50 ml. The mushrooms go from harvest to extraction without a drying step, which as far as we know makes us one of very few growers in the world to do so; the fresh versus dried page explains what that does and does not change, and the extraction-ratio page explains why “1:3” on a fresh-mushroom label is not the same 1:3 as on a dried one. The beta-glucan content of the dried extract is 23.21%, measured by TÜV Austria. We do not publish a milligram-per-millilitre figure because deriving one from a dry-basis percentage would require an extraction-yield number we have not verified. The dosage guide covers the four-week titration we suggest, and the timing and stacking guide covers when in the day to take it.

Fruiting body or mycelium — which did the studies use?

Mycelium, mostly — and that fact is worth stating plainly on a site that sells fruiting-body extracts. PSK is produced from cultured mycelium of the CM-101 strain and PSP from the COV-1 strain, grown in liquid culture, then purified; the 2026 vaccination trial used a mycelium product too. The fruiting body has its own literature — the immune-active protein YZP was purified from fruiting bodies, and the phase-1 study used a fruiting-body preparation — but the famous numbers come from purified mycelial products.

So the argument for fruiting bodies is not that mycelium is inert; it is about what is sold under that name. The pharmaceutical products are purified polysaccharides with the culture medium removed. The consumer products called “mycelium” are usually mycelium grown on rice or oats and ground up together with the grain, so that most of the powder is starch — the fruiting body versus mycelium page and the mycelium debate page go through the evidence and the measurements without name-calling. Our position is the measurable one: a fruiting-body extract from the whole mushroom, alpha-glucan (starch) reported as not detected, and the beta-glucan percentage tested on the finished extract. A purified PSP would score well on that test too. A rice-mycelium powder would not.

Why do we sell turkey tail with reishi — and why is our pure turkey tail extract untested?

Two honest answers. We pair turkey tail with reishi because the human evidence divides that way: turkey tail’s polysaccharides are the immune-activating half, with the largest clinical literature in the field, and reishi is the mushroom whose human trials point to regulation rather than stimulation — the balance the original article kept promising. Together they cover both directions the immune trials describe. And our pure turkey tail extract has not been sent for its own beta-glucan test: only four of our extracts have been tested, and the turkey tail and reishi blend is one of them. The blend’s 23.21% belongs to the blend.

We could have printed the blend’s figure next to the pure extract, or averaged something. We did not, and the rule on this site is that a lab test equals a verified product: the pure turkey tail extract is described as a fruiting-body triple extract at 1:3 from the Galilee, and nothing more, until it is tested. If a beta-glucan number is what you want from turkey tail, buy the blend, whose report is open on the lab-testing page. The how to read a COA guide walks through that report line by line, and the complete reishi guide holds reishi’s side of the case. The original article’s “who might find this interesting” list is kept below.

Who should not take turkey tail?

Anyone on an immunosuppressant or biologic, anyone with an autoimmune condition or a transplant, and anyone in cancer treatment who has not discussed it with their oncologist — precisely because turkey tail’s compounds are immune-active and because the cancer literature, impressive as it is, concerns a prescription product used under medical supervision. For our blend, add reishi’s anti-platelet activity: anyone on blood thinners, and anyone due for surgery within two weeks. By our own rule rather than by evidence of harm, anyone pregnant, breastfeeding or under 18, because our tinctures contain alcohol and no safety research exists in those groups. Mushroom allergy exists and is a reason to stop at the first sign of a reaction. The full breakdown — every human trial with dose, duration and what was measured, the case-report search, and where the “low platelets” warning actually came from — is on Who shouldn’t take turkey tail.

We keep this on a sales page on purpose. The pregnancy and breastfeeding page and the children’s page explain the “no” in those groups in detail; the drug-interactions page covers immunosuppressants and anticoagulants. The original article’s closing note is kept in the last section of this page.

How long before turkey tail shows anything?

In the trials, gut bacteria shifted within 8 weeks, immune-cell counts within 4 months in healthy adults and 4 weeks in patients, and NK-cell function trended upward within 6 weeks. No trial has measured how long a healthy adult takes to feel anything, because none asked, and “feel” is not what turkey tail’s compounds have been shown to change. If you take it for immune support through a winter, the only fair test is the winter: note every cold, its length and severity, in the season before and the season on.

Our general guidance is on the how long do medicinal mushrooms take to work page, including a simple one-person protocol so that you are not fooled by chance. A 50 ml bottle at 1.4 ml a day is about 35 days, which covers the four-week window the shortest trials used. The original article’s summary is kept below.

What does the research still not know?

Whether a fruiting-body turkey tail extract, at a supplement dose, does in a healthy adult what PSP and PSK do in patients — no trial has tested one. Whether turkey tail lowers any marker of inflammation in a person — no trial has measured one. Whether the immune-cell changes in the 100-person trial belong to turkey tail, to danshen, or to both. Whether the prebiotic shift seen with PSP happens with an extract, and whether it changes how anyone’s digestion feels. And whether a healthy adult taking turkey tail through a winter catches fewer colds — the question everyone buying it is asking, and the one nobody has studied.

What we can measure, we do: the blend’s beta-glucan content on the finished extract, its heavy-metal, pesticide and PAH results, the ratio of fresh mushroom to liquid. “400 clinical trials” is not something we can put on a certificate for our bottle. A laboratory result is, which is why the proof panel below this article shows a percentage with a report number, and why the pure turkey tail extract shows none.

The bottom line

Turkey tail is the medicinal mushroom with the best clinical evidence in the field and the widest gap between that evidence and the product on the shelf. Its purified polysaccharides, PSK and PSP, improved survival alongside cancer treatment in meta-analyses of thousands of patients and are prescription products in Japan and China; in healthy adults, the mushroom raised immune-cell counts over four months (combined with another herb) and acted as a prebiotic over eight weeks; no human study has measured inflammation, and none has tested a tincture. Choose a fruiting-body extract whose beta-glucan is measured on the finished product, understand that the number belongs to the extract that was tested and not to its neighbour on the shelf, take it daily for at least a month and judge it over a season, and talk to your physician first if your immune system is medically suppressed, medically overactive, or under treatment.

Frequently asked questions about turkey tail

How this article began (the original 2025 closing notes, kept)

This page was first published as a short educational overview and rebuilt in September 2026 around the trial table above. Nothing was thrown away: every section of the original sits in a grey box under the question it answers, and its closing notes — which drew the pharmaceutical-versus-supplement line correctly from the start — are here.

Sources (peer-reviewed)

1. Yun zhi (PSP-rich) + danshen for 4 months in 100 healthy adults — higher T-helper cells, CD4/CD8 ratio and interferon-gamma; no liver or kidney effects. Wong CK, Tse PS, Wong EL, et al. International Immunopharmacology, 2004. View on PubMed
2. Turkey tail polysaccharopeptide vs amoxicillin in 24 healthy volunteers, 8 weeks — PSP acted as a prebiotic. Pallav K, Dowd SE, Villafuerte J, et al. Gut Microbes, 2014. View on PubMed
3. PSP product for 14 days in 12 healthy adults — no clinically significant CYP3A4 change. Nicandro JP, Tsourounis C, Frassetto L, et al. Journal of Herbal Pharmacotherapy, 2007. View on PubMed
4. Turkey tail preparation up to 9 g a day for 6 weeks after radiotherapy — phase 1, 9 women, safe, immune “trends”. Torkelson CJ, Sweet E, Martzen MR, et al. ISRN Oncology, 2012. View on PubMed
5. Yun zhi + danshen for 6 months in 82 women after breast-cancer treatment — higher T-helper and B-cell counts. Wong CK, Bao YX, Wong EL, et al. American Journal of Chinese Medicine, 2005. View on PubMed
6. PSP for 28 days in 68 patients with advanced lung cancer — higher leukocytes, IgG, IgM; fewer withdrawals for progression. Tsang KW, Lam CL, Yan C, et al. Respiratory Medicine, 2003. View on PubMed
7. PSK after gastric-cancer surgery — meta-analysis of 8 RCTs, 8,009 patients, hazard ratio 0.88. Oba K, Teramukai S, Kobayashi M, et al. Cancer Immunology, Immunotherapy, 2007. View on PubMed
8. PSK after colorectal-cancer surgery — meta-analysis of 3 RCTs, 1,094 patients, survival risk ratio 0.71. Sakamoto J, Morita S, Oba K, et al. Cancer Immunology, Immunotherapy, 2006. View on PubMed
9. Yun zhi and survival in cancer patients — systematic review and meta-analysis of 13 RCTs; 9% absolute reduction in 5-year mortality. Eliza WL, Fai CK, Chung LP. Recent Patents on Inflammation & Allergy Drug Discovery, 2012. View on PubMed
10. PSK and turkey tail extracts for lung cancer — systematic review of 28 studies. Fritz H, Kennedy DA, Ishii M, et al. Integrative Cancer Therapies, 2015. View on PubMed
11. Turkey tail extracts to reduce adverse effects of colorectal-cancer treatment — Cochrane review, 7 RCTs, 1,569 participants. Pilkington K, Wieland LS, Teng L, et al. Cochrane Database of Systematic Reviews, 2022. View on PubMed
12. Turkey tail extract in 15 patients with advanced liver cancer — no change in progression; better quality of life. Chay WY, Tham CK, Toh HC, et al. Journal of Alternative and Complementary Medicine, 2017. View on PubMed
13. Fomitopsis + turkey tail mycelia as a vaccination adjunct in 90 adults — safe; fewer side effects; antibodies preserved. Saxe G, Smith CN, Golshan S, et al. BMC Immunology, 2026. View on PubMed
14. Medicinal mushroom supplements in cancer — systematic review of 39 clinical studies; evidence “inconclusive” for routine use. Narayanan S, de Mores AR, Cohen L, et al. Current Oncology Reports, 2023. View on PubMed
15. PSP as an immunotherapeutic in China — composition (~60% polysaccharide, 10–30% peptide), mycelial source, 41 years of studies. Dou H, Chang Y, Zhang L. Progress in Molecular Biology and Translational Science, 2019. View on PubMed
16. PSK — mechanisms and clinical use; CM-101 and COV-1 strains. Fisher M, Yang LX. Anticancer Research, 2002. View on PubMed
17. Turkey tail polysaccharides in cancer therapy — targets and efficacy; review. Habtemariam S. Biomedicines, 2020. View on PubMed
18. Immunomodulatory dietary polysaccharides — systematic review; 15 controlled human studies. Ramberg JE, Nelson ED, Sinnott RA. Nutrition Journal, 2010. View on PubMed
19. Turkey tail fractions inhibit lipoxygenase and cyclooxygenase in vitro. Michalska A, Szymanowska U, Kapusta I, et al. Food Chemistry, 2025. View on PubMed
20. YZP, a fruiting-body protein, activates IL-10-producing regulatory B cells and eases colitis in mice. Kuan YC, Wu YJ, Hung CL, et al. PLoS One, 2013. View on PubMed
21. Agaricus blazei extract 900 mg a day for 60 days in 57 older women — no change in IL-6, IFN-γ or TNF-α. Lima CU, Souza VC, Morita MC, et al. Scandinavian Journal of Immunology, 2012. View on PubMed
22. Whole shiitake 5–10 g a day for 4 weeks in 52 healthy adults — lower C-reactive protein, higher salivary IgA. Dai X, Stanilka JM, Rowe CA, et al. Journal of the American College of Nutrition, 2015. View on PubMed
23. Agaricus blazei extract for 21 days in 50 patients with inflammatory bowel conditions — effect on systemic cytokines “limited”. Therkelsen SP, Hetland G, Lyberg T, et al. Scandinavian Journal of Immunology, 2016. View on PubMed

Further reading on this site: Turkey tail science · what turkey tail is · Reishi science · the research hub, filtered for immunity · turkey tail for immunity — our extract page · the complete guide to medicinal mushrooms · all solutions by goal · medicinal mushrooms and digestion · mushrooms for the immune system · reishi and inflammation.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.* This page is an educational overview of published research and does not constitute medical advice. Medicinal mushroom extracts are dietary supplements. Do not begin use while taking medication, during pregnancy or nursing, or with an existing medical condition, without consulting a physician.